Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 101–200 of 1,000
Zhang, J., Tao, R., Campbell, K. F., Carvalho, J. L., Ruiz, E. C., Kim, G. C., Schmuck, E. G., Raval, A. N., da Rocha, A. M., Herron, T. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09831-5 · Cited by 201
Funakoshi, S., Miki, K., Takaki, T., Okubo, C., Hatani, T., Chonabayashi, K., Nishikawa, M., Takei, I., Oishi, A., Narita, M., et al. (2016) · Scientific Reports · doi:10.1038/srep19111 · Cited by 196
Agarwal, P., Zhao, S., Bielecki, P., Rao, W., Choi, J. K., Zhao, Y., Yu, J., Zhang, W., & He, X. (2013) · Lab on a Chip · doi:10.1039/c3lc50678a · Cited by 190
Blauwkamp, T. A., Nigam, S., Ardehali, R., Weissman, I. L., & Nusse, R. (2012) · Nature Communications · doi:10.1038/ncomms2064 · Cited by 184
RETRACTED: Identification of a coronary vascular progenitor cell in the human heart
Bearzi, C., Leri, A., Lo Monaco, F., Rota, M., Gonzalez, A., Hosoda, T., Pepe, M., Qanud, K., Ojaimi, C., Bardelli, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907622106 · Cited by 192
RetractedStudy familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
Han, L., Li, Y., Tchao, J., Kaplan, A. D., Lin, B., Li, Y., Mich-Basso, J., Lis, A., Hassan, N., London, B., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu205 · Cited by 191
“iPSCs were differentiated into CMs using our previously established protocol.(12,13) The EBs were dissociated at around Day 24, seeded into 6-well plates and cultured as monolayers for additional 5 days.”
MethodSelf-citationSmall molecules that modulate embryonic stem cell fate and somatic cell reprogramming
Li, W., & Ding, S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.002 · Cited by 191
Generation of articular chondrocytes from human pluripotent stem cells
Craft, A. M., Rockel, J. S., Nartiss, Y., Kandel, R. A., Alman, B. A., & Keller, G. M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3210 · Cited by 186
Self-citationChan, S. S.-K., Shi, X., Toyama, A., Arpke, R. W., Dandapat, A., Iacovino, M., Kang, J., Le, G., Hagen, H. R., Garry, D. J., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.004 · Cited by 184
“Muchwork has been donewith the aim of facilitating this process by employing various signaling pathway modulators (Burridge et al., 2011; Kattman et al., 2011; Laflamme et al., 2007; Yang et al., 2008).”
BackgroundAutonomous beating rate adaptation in human stem cell-derived cardiomyocytes
Eng, G., Lee, B. W., Protas, L., Gagliardi, M., Brown, K., Kass, R. S., Keller, G., Robinson, R. B., & Vunjak-Novakovic, G. (2016) · Nature Communications · doi:10.1038/ncomms10312 · Cited by 176
Self-citationDuan, Y., Liu, Z., O’Neill, J., Wan, L. Q., Freytes, D. O., & Vunjak-Novakovic, G. (2011) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-011-9304-0 · Cited by 179
“Human ESC Culture The human ESCs (NIH code ES02) were obtained from ES Cell International [3].”
InfluentialJawad, H., Lyon, A. R., Harding, S. E., Ali, N. N., & Boccaccini, A. R. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn026 · Cited by 181
Cardiac muscle regeneration: lessons from development
Mercola, M., Ruiz-Lozano, P., & Schneider, M. D. (2011) · Genes & Development · doi:10.1101/gad.2018411 · Cited by 173
“Wnts and the TGFb familymemberNodal play evolutionarily conserved roles in inducing mesoderm and endoderm; thus, they are important to promote cardiogenic differentiation and, for this reason, arewidely used to initiate cardiogenesis in ESC cultures (for example, see Xu et al. 2006; Yang et al. 2008).”
BackgroundGeneration of the epicardial lineage from human pluripotent stem cells
Witty, A. D., Mihic, A., Tam, R. Y., Fisher, S. A., Mikryukov, A., Shoichet, M. S., Li, R.-K., Kattman, S. J., & Keller, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3002 · Cited by 180
Self-citationMesp1: A Key Regulator of Cardiovascular Lineage Commitment
Bondue, A., & Blanpain, C. (2010) · Circulation Research · doi:10.1161/circresaha.110.227058 · Cited by 168
Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes
Lieu, D. K., Fu, J.-D., Chiamvimonvat, N., Tung, K. C., McNerney, G. P., Huser, T., Keller, G., Kong, C.-W., & Li, R. A. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.973420 · Cited by 179
“5 ng/mL bone morphogenetic protein (BMP) 4 in STEMPRO 34 media as described.(13) From days 1 to 4 the EBs were induced with 10 ng/mL BMP4, 5 ng/mL basic fibroblast growth factor (bFGF), and 3 ng/mL activin A, and then from days 4 to 8 they were cultured in 150 ng/mL DKK1 and 10 ng/mL vascular endothelial growth factor.”
MethodSelf-citationVallier, L., Touboul, T., Brown, S., Cho, C., Bilican, B., Alexander, M., Cedervall, J., Chandran, S., Ährlund-Richter, L., Weber, A., et al. (2009) · Stem Cells · doi:10.1002/stem.199 · Cited by 174
iPS cells: A source of cardiac regeneration
Yoshida, Y., & Yamanaka, S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.026 · Cited by 171
Chen, V. C., Ye, J., Shukla, P., Hua, G., Chen, D., Lin, Z., Liu, J.-C., Chai, J., Gold, J., Wu, J., et al. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.08.002 · Cited by 174
Scully, S., Francescone, R., Faibish, M., Bentley, B., Taylor, S. L., Oh, D., Schapiro, R., Moral, L., Yan, W., & Shao, R. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2017-12.2012 · Cited by 164
“The current finding of Flk-1 in GSC transdifferentiation is also in line with previous data that Flk-1 has a key role in the transdifferentiation of embryonic stem cells into vascular cells (Yamashita et al., 2000; Yang et al., 2008; Taura et al., 2009).”
BackgroundResultYoshida, Y., & Yamanaka, S. (2010) · Circulation · doi:10.1161/circulationaha.109.881433 · Cited by 172
High-efficiency RNA-based reprogramming of human primary fibroblasts
Kogut, I., McCarthy, S. M., Pavlova, M., Astling, D. P., Chen, X., Jakimenko, A., Jones, K. L., Getahun, A., Cambier, J. C., Pasmooij, A. M. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03190-3 · Cited by 166
Nourse, M. B., Halpin, D. E., Scatena, M., Mortisen, D. J., Tulloch, N. L., Hauch, K. D., Torok-Storb, B., Ratner, B. D., Pabon, L., & Murry, C. E. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194233 · Cited by 168
Fu, J.-D., Rushing, S. N., Lieu, D. K., Chan, C. W., Kong, C.-W., Geng, L., Wilson, K. D., Chiamvimonvat, N., Boheler, K. R., Wu, J. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027417 · Cited by 170
“cardiovascular progenitors into CMs using the activin, BMP-4 and VEGF induction was as reported”
MethodSelf-citationYokoo, N., Baba, S., Kaichi, S., Niwa, A., Mima, T., Doi, H., Yamanaka, S., Nakahata, T., & Heike, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.052 · Cited by 165
“differentiation as previously described [ 19 ].”
BackgroundResultInfluentialDoss, M. X., Di Diego, J. M., Goodrow, R. J., Wu, Y., Cordeiro, J. M., Nesterenko, V. V., Barajas-Martínez, H., Hu, D., Urrutia, J., Desai, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040288 · Cited by 169
Biomimetic 3D tissue models for advanced high-throughput drug screening
Nam, K.-H., Smith, A. S. T., Lone, S., Kwon, S., & Kim, D.-H. (2015) · SLAS Technology · doi:10.1177/2211068214557813 · Cited by 171
Empowering self-renewal and differentiation: the role of mitochondria in stem cells
Rehman, J. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0678-2 · Cited by 163
“For the purpose of regenerative cardiovascular therapies, human ESCs have been successfully used to generate functional cardiomyocytes and vascular cells [8–11].”
Hadas, Y., Vincek, A. S., Youssef, E., Żak, M. M., Chepurko, E., Sultana, N., Sharkar, M. T. K., Guo, N., Komargodski, R., Kurian, A. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041882 · Cited by 165
Karakikes, I., Senyei, G. D., Hansen, J., Kong, C.-W., Azeloglu, E. U., Stillitano, F., Lieu, D. K., Wang, J., Ren, L., Hulot, J.-S., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0110 · Cited by 169
Sinha, S., Iyer, D., & Granata, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1554-3 · Cited by 180
“Subsequently, Yang and Keller used a staged approach to model embryological events which involved activin A, BMP4, and FGF2 to establish a primitive streak-like population, then Dikkopf 1 homolog (DKK1) and vascular endothelial growth factor (veGF) to induce cardiac mesoderm followed by the addition of FGF2 to expand…”
MethodSmall Molecules Enable Cardiac Reprogramming of Mouse Fibroblasts with a Single Factor, Oct4
Wang, H., Cao, N., Spencer, C. I., Nie, B., Ma, T., Xu, T., Zhang, Y., Wang, X., Srivastava, D., & Ding, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.038 · Cited by 166
Engineering bone tissue from human embryonic stem cells
Marolt, D., Campos, I. M., Bhumiratana, S., Koren, A., Petridis, P., Zhang, G., Spitalnik, P. F., Grayson, W. L., & Vunjak-Novakovic, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201830109 · Cited by 164
Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Lee, Y.-K., Ng, K.-M., Lai, W.-H., Chan, Y.-C., Lau, Y.-M., Lian, Q., Tse, H.-F., & Siu, C.-W. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9273-3 · Cited by 154
“Cardiac differentiation was performed according to a published protocol [ 20 ].”
MethodCloche is a bHLH-PAS transcription factor that drives haemato-vascular specification
Reischauer, S., Stone, O. A., Villasenor, A., Chi, N., Jin, S.-W., Martin, M., Lee, M. T., Fukuda, N., Marass, M., Witty, A., et al. (2016) · Nature · doi:10.1038/nature18614 · Cited by 162
Protze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
Self-citationMicropattern width dependent sarcomere development in human ESC-derived cardiomyocytes
Salick, M. R., Napiwocki, B. N., Sha, J., Knight, G. T., Chindhy, S. A., Kamp, T. J., Ashton, R. S., & Crone, W. C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.001 · Cited by 159
“Researchers have produced cardiac phenotypes by applying growth factors Activin A and BMP4 to embryoid bodies [4] andmonolayers [5,6].”
Abilez, O. J., Tzatzalos, E., Yang, H., Zhao, M.-T., Jung, G., Zöllner, A. M., Tiburcy, M., Riegler, J., Matsa, E., Shukla, P., et al. (2018) · Stem Cells · doi:10.1002/stem.2732 · Cited by 153
Present state and future perspectives of using pluripotent stem cells in toxicology research
Wobus, A. M., & Löser, P. (2011) · Archives of Toxicology · doi:10.1007/s00204-010-0641-6 · Cited by 159
“%) of functional cardiomyocytes (Yang et al. 2008).”
Tbx1 Regulates Proliferation and Differentiation of Multipotent Heart Progenitors
Chen, L., Fulcoli, F. G., Tang, S., & Baldini, A. (2009) · Circulation Research · doi:10.1161/circresaha.109.200295 · Cited by 161
Scalable GMP compliant suspension culture system for human ES cells
Chen, V. C., Couture, S., Ye, J., Lin, Z., Hua, G., Huang, H.-I. P., Wu, J., Hsu, D. S., Carpenter, M. K., & Couture, L. A. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.02.001 · Cited by 172
“H9 cell aggregates from day 3 or 4 suspension culture were directly induced to cardiomyocyte differentiation in a spinner flask using a serum-free and stage specific induction method (Yang et al., 2008).”
MethodBardot, E., & Hadjantonakis, A. (2020) · Mechanisms of Development · doi:10.1016/j.mod.2020.103617 · Cited by 169
“This dynamic signaling environment is critical for correct differentiation of the cardiac lineage and has been recapitulated in directed differentiation of pluripotent stem cells (PSCs) to cardiomyocytes in vitro (Lian et al., 2013; Yang et al., 2008).”
BackgroundCan We Engineer a Human Cardiac Patch for Therapy?
Zhang, J. J., Zhu, W., Radisic, M., & Vunjak‐Novakovic, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.311213 · Cited by 164
Induced Pluripotent Stem Cells for Regenerative Medicine
Hirschi, K. K., Li, S., & Roy, K. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105108 · Cited by 148
Mauritz, C., Martens, A., Rojas, S. V., Schnick, T., Rathert, C., Schecker, N., Menke, S., Glage, S., Zweigerdt, R., Haverich, A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr166 · Cited by 153
Smith, A. S. T., Macadangdang, J. R., Leung, W. W., Laflamme, M. A., & Kim, D. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.002 · Cited by 169
“In such systems, the serial application of activin A and BMP-4 growth factors in RPMI-B27 medium has proven ef fi cacious in yielding N 50% contracting cardiomyocytes (Yang et al., 2008, Zhu et al., 2011).”
Advanced cell culture platforms: a growing quest for emulating natural tissues
Mirbagheri, M., Adibnia, V., Hughes, B. R., Waldman, S. D., Banquy, X., & Hwang, D. K. (2019) · Materials Horizons · doi:10.1039/c8mh00803e · Cited by 168
In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix
Lee, J., Sutani, A., Kaneko, R., Takeuchi, J., Sasano, T., Kohda, T., Ihara, K., Takahashi, K., Yamazoe, M., Morio, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18031-5 · Cited by 154
Creation of human cardiac cell sheets using pluripotent stem cells
Matsuura, K., Wada, M., Shimizu, T., Haraguchi, Y., Sato, F., Sugiyama, K., Konishi, K., Shiba, Y., Ichikawa, H., Tachibana, A., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.089 · Cited by 165
“Many recent reports have suggested that human pluripotent stem cells, including ESCs and induced pluripotent stem cells (hiPSCs), differentiate into cardiomyocytes through embryoid body (EB) formation [10,11] and monolayer culture [12,13].”
BackgroundRen, Y., Lee, M. Y., Schliffke, S., Paavola, J., Amos, P. J., Ge, X., Ye, M., Zhu, S., Senyei, G., Lum, L., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.04.012 · Cited by 148
Circulating Dickkopf-1 Is Correlated with Bone Erosion and Inflammation in Rheumatoid Arthritis
WANG, S.-Y., LIU, Y.-Y., YE, H., GUO, J.-P., LI, R., LIU, X., & LI, Z.-G. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100089 · Cited by 150
Grigoriadis, A. E., Kennedy, M., Bozec, A., Brunton, F., Stenbeck, G., Park, I.-H., Wagner, E. F., & Keller, G. M. (2010) · Blood · doi:10.1182/blood-2009-07-234690 · Cited by 151
Self-citationMicrofabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle
Xiao, Y., Zhang, B., Liu, H., Miklas, J. W., Gagliardi, M., Pahnke, A., Thavandiran, N., Sun, Y., Simmons, C., Keller, G., et al. (2014) · Lab Chip · doi:10.1039/c3lc51123e · Cited by 144
Self-citationCardiogenic Differentiation and Transdifferentiation of Progenitor Cells
Reinecke, H., Minami, E., Zhu, W., & Laflamme, M. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.180588 · Cited by 161
Lyra‐Leite, D. M., Gutiérrez‐Gutiérrez, Ó., Wang, M., Zhou, Y., Cyganek, L., & Burridge, P. W. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101560 · Cited by 161
Steinhauser, M. L., & Lee, R. T. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100175 · Cited by 168
“One could envision a similar strategy using cardiogenic intermediates that express any of the previously mentioned transcription factors associated with cardiac progenitors or cell surfacemarkers such as the receptor for vascular endothelial growth factor (Flk1/KDR) (Yang et al, 2008).”
BackgroundMethodGlioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation
Francescone, R., Scully, S. J., Bentley, B., Yan, W., Taylor, S. L., Oh, D. S., Moral, L. A., & Shao, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334540 · Cited by 157
Wang, P., Rodriguez, R. T., Wang, J., Ghodasara, A., & Kim, S. K. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.01.017 · Cited by 158
Paik, D. T., Tian, L., Lee, J., Sayed, N., Chen, I. Y., Rhee, S., Rhee, J.-W., Kim, Y., Wirka, R. C., Buikema, J. W., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312913 · Cited by 147
Hartman, M. E., Dai, D.-F., & Laflamme, M. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.004 · Cited by 138
“Manipulation of Wnt signaling—Wnt/β-catenin signaling plays a biphasic role in heart development with early canonical Wnt ligands stimulating mesoderm induction, while Wnt activation at later timepoints inhibits cardiogenesis [32, 35, 51, 52].”
BackgroundMethodInfluentialAtomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes
Liu, J., Sun, N., Bruce, M. A., Wu, J. C., & Butte, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037559 · Cited by 138
Human primordial germ cell commitment in vitro associates with a unique PRDM14 expression profile
Sugawa, F., Araúzo-Bravo, M. J., Yoon, J., Kim, K.-P., Aramaki, S., Wu, G., Stehling, M., Psathaki, O. E., Hübner, K., & Schöler, H. R. (2015) · The EMBO Journal · doi:10.15252/embj.201488049 · Cited by 144
“Treatment of human ESCs with a combination of Activin A (ActA) and BMP4 under serum-free conditions has been found to induce the formation of primitive streak-like cell populations and mesoderm (Yang et al , 2008).”
Später, D., Hansson, E. M., Zangi, L., & Chien, K. R. (2014) · Development · doi:10.1242/dev.091538 · Cited by 143
“Addition of defined factors, such as FGF2, VEGFA and DKK1, and inhibition of Nodal or TGFβ receptor 2 signaling, enhanced the efficiency of cardiomyocyte differentiation to greater than 50% (Cai et al., 2013; Kattman et al., 2011; Laflamme et al., 2007; Willems et al., 2012; Yang et al., 2008).”
BackgroundInfluentialWang, K., Lin, R., Hong, X., Ng, A. H. M., Lee, C. N., Neumeyer, J., Wang, G., Wang, X., Ma, M., Pu, W. T., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba7606 · Cited by 152
Maidhof, R., Tandon, N., Lee, E. J., Luo, J., Duan, Y., Yeager, K., Konofagou, E., & Vunjak-Novakovic, G. (2012) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.525 · Cited by 138
“These principles of biophysical conditioning should prove useful for the development of cardiac patches, starting from clinically relevant cardiac cells, such as embryonic (Yang et al., 2008) or induced plouripotent stem cells (Moretti et al.”
BackgroundKraehenbuehl, T. P., Ferreira, L. S., Hayward, A. M., Nahrendorf, M., van der Vlies, A. J., Vasile, E., Weissleder, R., Langer, R., & Hubbell, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.005 · Cited by 141
“The first hESC-based preclinical animal studies for repairing infarcted cardiac tissue used cardiomyocytes [6,7] or vascular cells [8,9].”
Cardiac Differentiation of Pluripotent Stem Cells
Rajala, K., Pekkanen-Mattila, M., & Aalto‐Setälä, K. (2011) · Stem Cells International · doi:10.4061/2011/383709 · Cited by 157
“These cardiovascular progenitor cells have recently also been identified in early pluripotent stem cell derivatives [5, 57].”
BackgroundMethodInfluentialEarly cardiac development: a view from stem cells to embryos
Vliet, P. P. V., Wu, S. M., Zaffran, S., & Pucéat, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs270 · Cited by 151
Fetal Cells Traffic to Injured Maternal Myocardium and Undergo Cardiac Differentiation
Kara, R. J., Bolli, P., Karakikes, I., Matsunaga, I., Tripodi, J., Tanweer, O., Altman, P. R., Shachter, N. S., Nakano, A., Najfeld, V., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.249037 · Cited by 147
Ruan, J.-L., Tulloch, N. L., Saiget, M., Paige, S. L., Razumova, M. V., Regnier, M., Tung, K. C., Keller, G., Pabon, L., Reinecke, H., et al. (2015) · Stem Cells · doi:10.1002/stem.2036 · Cited by 131
Self-citationDeveloping safe therapies from human pluripotent stem cells
Carpenter, M. K., Frey-Vasconcells, J. L., & Rao, M. S. (2009) · Nature Biotechnology · doi:10.1038/nbt0709-606 · Cited by 150
Myocardial Tissue Engineering: In Vitro Models
Vunjak Novakovic, G., Eschenhagen, T., & Mummery, C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014076 · Cited by 132
“We also investigated cardiogenesis and maturation of human cardiomyocytes derived by staged molecular induction of embryonic stem cells (Yang et al. 2008) in hydrogels derived by blending native cardiac extracellular matrix (ECM) with type I collagen without any additional growth factors (Duan et…”
MethodOrgan repair and regeneration: An overview
Baddour, J. A., Sousounis, K., & Tsonis, P. A. (2012) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21006 · Cited by 133
Murine “Cardiospheres” Are Not a Source of Stem Cells with Cardiomyogenic Potential
Andersen, D. C., Andersen, P., Schneider, M., Jensen, H. B., & Sheikh, S. P. (2009) · Stem Cells · doi:10.1002/stem.72 · Cited by 134
Cao, N., He, L., Huang, J., Wang, J., Chen, Y., Chen, Z., & Yang, H. (2013) · Cell Research · doi:10.1038/cr.2013.102 · Cited by 143
Adeno-Associated Virus Biology
Weitzman, M. D., & Linden, R. M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_1 · Cited by 132
Self-citationSlukvin, I. I. (2013) · Blood · doi:10.1182/blood-2013-07-474825 · Cited by 143
Bondue, A., Tännler, S., Chiapparo, G., Chabab, S., Ramialison, M., Paulissen, C., Beck, B., Harvey, R., & Blanpain, C. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201007063 · Cited by 127
“…MCPs during embryonic de velopment, mouse and human bipotent and tripotent MCPs have been isolated during ESC differentiation, giving rise to CMs, SMCs, and ECs similar to their in vivo potential (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Bu et al., 2009).”
Mordwinkin, N. M., Burridge, P. W., & Wu, J. C. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9423-2 · Cited by 128
“Current differentiation methods are designed around small-scale research paradigms [90].”
Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts
Zhang, Y., Cao, N., Huang, Y., Spencer, C. I., Fu, J.-D., Yu, C., Liu, K., Nie, B., Xu, T., Li, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.001 · Cited by 128
“BMP, Activin A, and Wnt are key signaling molecules that synergistically induce mesoderm and subsequent CPC formation (Yang et al., 2008; Kattman et al., 2011).”
BackgroundSanchez-Freire, V., Lee, A. S., Hu, S., Abilez, O. J., Liang, P., Lan, F., Huber, B. C., Ong, S.-G., Hong, W. X., Huang, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.056 · Cited by 124
Induced pluripotent stem cells: developmental biology to regenerative medicine
Nelson, T. J., Martinez‐Fernandez, A., & Terzic, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.159 · Cited by 138
Hulot, J.-S., Stillitano, F., Salem, J. E., Kovacic, J. C., Fuster, V., & Hajjar, R. J. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt390 · Cited by 126
Conversion of Human Fibroblasts to Functional Endothelial Cells by Defined Factors
Li, J., Huang, N. F., Zou, J., Laurent, T. J., Lee, J. C., Okogbaa, J., Cooke, J. P., & Ding, S. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301167 · Cited by 124
“To determine whether the endothelial transdifferentiation program encompassed the formation of mesodermal progenitors, we accessed the temporal expression kinetics of Flk1,(18) a typical marker of mesodermal progenitors.(19,20) The expression of Flk1 reached a high level at day 18 and then decreased by day 28, indicat…”
BackgroundStem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts
Rikhtegar, R., Pezeshkian, M., Dolati, S., Safaie, N., Rad, A. A., Mahdipour, M., Nouri, M., Jodati, A., & Yousefi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.065 · Cited by 135
Brafman, D. A., Phung, C., Kumar, N., & Willert, K. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.138 · Cited by 126
Keith, M. C. L., & Bolli, R. (2015) · Circulation Research · doi:10.1161/circresaha.116.305557 · Cited by 135
Lecina, M., Ting, S., Choo, A., Reuveny, S., & Oh, S. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0104 · Cited by 123
Cardiopoietic Factors: Extracellular Signals for Cardiac Lineage Commitment
Noseda, M., Peterkin, T., Simões, F. C., Patient, R., & Schneider, M. D. (2011) · Circulation Research · doi:10.1161/circresaha.110.223792 · Cited by 120
Lin, B., Li, Y., Han, L., Kaplan, A. D., Ao, Y., Kalra, S., Bett, G. C. L., Rasmusson, R. L., Denning, C., & Yang, L. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019505 · Cited by 116
“This cardiac differentiation method was developed from our previous cardiovascular differentiation protocol in human ES cells (Yang et al., 2008) and has been utilized for”
MethodSelf-citationFujiwara, M., Yan, P., Otsuji, T. G., Narazaki, G., Uosaki, H., Fukushima, H., Kuwahara, K., Harada, M., Matsuda, H., Matsuoka, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016734 · Cited by 123
Chen, A., Lieu, D. K., Freschauf, L., Lew, V., Sharma, H., Wang, J., Nguyen, D., Karakikes, I., Hajjar, R. J., Gopinathan, A., et al. (2011) · Advanced Materials · doi:10.1002/adma.201103463 · Cited by 122
Reynolds, J. G., Geretti, E., Hendriks, B. S., Lee, H., Leonard, S. C., Klinz, S. G., Noble, C. O., Lücker, P. B., Zandstra, P. W., Drummond, D. C., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.008 · Cited by 122
Cardiac Development and Implications for Heart Disease
Epstein, J. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1003941 · Cited by 135
Stem cell therapy for cardiac disease
Bernstein, H. S., & Srivastava, D. (2012) · Pediatric Research · doi:10.1038/pr.2011.61 · Cited by 134
“established a three-stage protocol that supports cardiac development at high frequency in differentiating hESC cultures (51).”
Magdy, T., Schuldt, A. J. T., Wu, J. C., Bernstein, D., & Burridge, P. W. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053110 · Cited by 109
Human Cardiospheres Are a Source of Stem Cells with Cardiomyogenic Potential
Davis, D. R., Smith, R. R., & Marbán, E. (2010) · Stem Cells · doi:10.1002/stem.413 · Cited by 119
Optimizing Cardiac Delivery of Modified mRNA
Sultana, N., Magadum, A., Hadas, Y., Kondrat, J., Singh, N., Youssef, E., Calderon, D., Chepurko, E., Dubois, N., Hajjar, R. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.016 · Cited by 112
“hPSC Differentiation The hPSCs (H9) were differentiated along a cardiac lineage as previously described.(37) Briefly, hPSCs were maintained in E8 media and”
MethodViđarsson, H., Hyllner, J., & Sartipy, P. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9113-x · Cited by 128
“In addition, cardiovascular progenitor cells have more recently also been identified in early hESC-derivatives [ 41 ].”
BackgroundOtsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., & Nakatsuji, N. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.01.002 · Cited by 117
“KhES-1 cells rarely formed beating colonies, regardless of whether embryoid bodymediated methods (Jang et al., 2008; Yang et al., 2008) or the END-2 coculture system (Passier et al.”
BackgroundMethod
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.